Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM
Go back to Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM| (NASDAQ: BBIO) | Delayed: 66.65 -0.66 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.31 | 52 Week High | $ | |||
| Open | $67.39 | 52 Week Low | $ | |||
| Day High | $67.56 | P/E | N/A | |||
| Day Low | $66.10 | EPS | $ | |||
| Volume | 796,788 | |||||
